Tissue of Origin: Breast
Cancer Type: Ductal Breast Carcinoma
HCC1954-LCC2 is a human breast cancer cell line.
This cell line was established from a breast metastasis in a 61 year old female with breast carcinoma
- Joan Massague, PhD, Member and Laboratory Head, Cancer Biology & Genetics Program; Marie-Josee and Henry Kravis Foundation Chair; Director, Sloan-Kettering Institute, Memorial Sloan Kettering
PubMed=27015306; DOI=10.1016/j.cell.2016.02.025 Malladi S., Macalinao D.G., Jin X., He L., Basnet H., Zou Y., de Stanchina E., Massague J. Metastatic latency and immune evasion through autocrine Inhibition of WNT. Cell 165:45-60(2016)
This cell line may be licensed nonexclusively for research or commercial purposes.
For internal research purposes by a commercial entity: Utilize MSK’s Express License, attached here. In order to streamline and expedite the licensing of select MSK cell lines, the terms of this non-exclusive license are non-negotiable. Please note: This license is only available for select cell lines, including this one.
To proceed, please download this contract, fill in all relevant fields, and email a scanned version to TRMOTDRTM@mskcc.org. Once this license has been executed by MSK, you will receive a signed copy and invoice, and can then place your order with ATCC.
For licensing requests for a commercial purpose: Contact MSK’s Tangible Materials team at TRMOTDRTM@mskcc.org.
For non-licensing requests from academic-research institutions: Contact Frances Weis-Garcia, PhD, Associate Laboratory Member/Head, Antibody & Bioresource Core Facility, MSK, 646-888-2354, firstname.lastname@example.org.